Page last updated: 2024-10-25

cisapride and Endotoxemia

cisapride has been researched along with Endotoxemia in 1 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, XS1
Jiang, F1

Other Studies

1 other study available for cisapride and Endotoxemia

ArticleYear
Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2006, Volume: 5, Issue:4

    Topics: Cisapride; Endotoxemia; Endotoxins; Fatty Liver; Female; Gastrointestinal Agents; Gastrointestinal T

2006